Integra LifeSciences Shareholders Face Steep Losses as Stock Plummets 84% Over Five Years
Long-term investors in Integra LifeSciences Holdings have seen their holdings decimated, with the stock's dramatic decline raising questions about the medical device maker's turnaround prospects and broader sector challenges.